The European Partnership for Personalised Medicine  introduces two exciting opportunities for start-ups, researchers, and early-stage teams working on cutting-edge solutions in personalized medicine. These programmes aim to accelerate the development, validation, and market readiness of transformative innovations that enhance patient care.

Fast Track Validation Programme

Designed to address a critical bottleneck in personalized medicine development, this programme supports validation studies to elevate projects to higher technological and market readiness levels.

• Who Can Apply? Start-up or a team/researcher affiliated with an academic or healthcare research organization. Solutions must be at least at proof-of-concept stage (TRL3).
• Funding & Support: Up to €80,000 per project for validation services. Collaboration with top-tier validation centers.
• Key Dates: Submission Deadline: 13 March 2025.
• Expected Outcomes: Projects gain critical evidence, improve TRL levels, and advance towards commercialization.

OR

Venture Creation Programme

This programme empowers early-stage ventures or teams in personalized medicine by bridging the gap between innovation and commercialization through mentoring, business model development, and customer discovery.

• Who Can Apply? Teams and early-stage start-ups
• Programme Highlights: A three-phase structure: The Meeting Place, The Deep Dive, and Business Model Validation. Intensive mentoring and pitch sessions to build robust business models.
• Key Dates: Submission Deadline: 13 March 2025.
• Expected Outcomes: Teams develop validated business models and gain skills for future entrepreneurial endeavors.